CLINICAL_TRIALS
trial_result
· 2013-07-30
Clinical Trial Update: Compare Aquacel® Ag Versus Mepilex® Border Ag to Manage Bioburden in Leg Ulcers [Phase 3]
Summary
Phase 3 trial comparing Aquacel Ag with Mepilex Border Ag for reducing bioburden in leg ulcers completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ConvaTec Inc. | Conditions: Leg Ulcers | Phase 3 | Status: COMPLETED